Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.

@article{Oyen2000FollowupRO,
  title={Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.},
  author={Wim J. G. Oyen and Claudia E. Verhagen and E Saris and Wim J M van den Broek and Gerlach F. F. M. Pieters and F H Corsten},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2000},
  volume={41 4},
  pages={643-6}
}
UNLABELLED For differentiated, nonmedullary thyroid carcinoma, postsurgical ablation of thyroid remnants and treatment of residual tumor and metastases with 131I is a potentially curative therapy. The aim of this study was to optimize the diagnostic protocol for the follow-up of thyroidectomized patients. METHODS Two hundred fifty-four patients (187 females, 67 males; mean age, 45 y; range, 8-83 y) were studied retrospectively for a mean follow-up period of 2.7 y (range, 1-12.5 y). An… CONTINUE READING
13 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Fluorine - 18 - FDG and iodine - l 3 l - iodide uptake in thyroid cancer

  • JP vandenBergh, OF Pieters, LV Beex, HA Ross, FH Corstens, AG Smals
  • J Nuci Med Cancer in North America 1999 †” 1994
  • 1998

Thallium - 20 I scintigraphy to predict therapeutic outcome of iodine - l 3 l therapy of metastatic thyroid carcinoma

  • JM Carril, R Quirce, J Serrano
  • J Nuci Med
  • 1998

Similar Papers

Loading similar papers…